638 related articles for article (PubMed ID: 27165744)
1. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Zheng S; Cherniack AD; Dewal N; Moffitt RA; Danilova L; Murray BA; Lerario AM; Else T; Knijnenburg TA; Ciriello G; Kim S; Assie G; Morozova O; Akbani R; Shih J; Hoadley KA; Choueiri TK; Waldmann J; Mete O; Robertson AG; Wu HT; Raphael BJ; Shao L; Meyerson M; Demeure MJ; Beuschlein F; Gill AJ; Sidhu SB; Almeida MQ; Fragoso MCBV; Cope LM; Kebebew E; Habra MA; Whitsett TG; Bussey KJ; Rainey WE; Asa SL; Bertherat J; Fassnacht M; Wheeler DA; ; Hammer GD; Giordano TJ; Verhaak RGW
Cancer Cell; 2016 May; 29(5):723-736. PubMed ID: 27165744
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic characterization of adrenocortical carcinoma.
Assié G; Letouzé E; Fassnacht M; Jouinot A; Luscap W; Barreau O; Omeiri H; Rodriguez S; Perlemoine K; René-Corail F; Elarouci N; Sbiera S; Kroiss M; Allolio B; Waldmann J; Quinkler M; Mannelli M; Mantero F; Papathomas T; De Krijger R; Tabarin A; Kerlan V; Baudin E; Tissier F; Dousset B; Groussin L; Amar L; Clauser E; Bertagna X; Ragazzon B; Beuschlein F; Libé R; de Reyniès A; Bertherat J
Nat Genet; 2014 Jun; 46(6):607-12. PubMed ID: 24747642
[TBL] [Abstract][Full Text] [Related]
4. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
5. Targeted Assessment of
Mohan DR; Lerario AM; Else T; Mukherjee B; Almeida MQ; Vinco M; Rege J; Mariani BMP; Zerbini MCN; Mendonca BB; Latronico AC; Marie SKN; Rainey WE; Giordano TJ; Fragoso MCBV; Hammer GD
Clin Cancer Res; 2019 Jun; 25(11):3276-3288. PubMed ID: 30770352
[TBL] [Abstract][Full Text] [Related]
6. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
Fojo T; Huff L; Litman T; Im K; Edgerly M; Del Rivero J; Pittaluga S; Merino M; Bates SE; Dean M
BMC Med Genomics; 2020 Nov; 13(1):165. PubMed ID: 33148256
[TBL] [Abstract][Full Text] [Related]
7. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
8. Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas.
Vatrano S; Volante M; Duregon E; Giorcelli J; Izzo S; Rapa I; Votta A; Germano A; Scagliotti G; Berruti A; Terzolo M; Papotti AM
Mod Pathol; 2018 Aug; 31(8):1257-1269. PubMed ID: 29581542
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
12. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
Jouinot A; Assie G; Libe R; Fassnacht M; Papathomas T; Barreau O; de la Villeon B; Faillot S; Hamzaoui N; Neou M; Perlemoine K; Rene-Corail F; Rodriguez S; Sibony M; Tissier F; Dousset B; Sbiera S; Ronchi C; Kroiss M; Korpershoek E; de Krijger R; Waldmann J; K D; Bartsch ; Quinkler M; Haissaguerre M; Tabarin A; Chabre O; Sturm N; Luconi M; Mantero F; Mannelli M; Cohen R; Kerlan V; Touraine P; Barrande G; Groussin L; Bertagna X; Baudin E; Amar L; Beuschlein F; Clauser E; Coste J; Bertherat J
J Clin Endocrinol Metab; 2017 Mar; 102(3):923-932. PubMed ID: 27967600
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract][Full Text] [Related]
18. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
19. Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.
De Martino MC; Al Ghuzlan A; Aubert S; Assié G; Scoazec JY; Leboulleux S; Do Cao C; Libè R; Nozières C; Lombès M; Pattou F; Borson-Chazot F; Hescot S; Mazoyer C; Young J; Borget I; Colao A; Pivonello R; Soria JC; Bertherat J; Schlumberger M; Lacroix L; Baudin E
J Clin Endocrinol Metab; 2013 Oct; 98(10):4080-8. PubMed ID: 23979958
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
